Mainardi J L, Shlaes D M, Goering R V, Shlaes J H, Acar J F, Goldstein F W
Laboratoire de Microbiologie Médicale, Fondation Hôpital Saint-Joseph, Paris, France.
J Infect Dis. 1995 Jun;171(6):1646-50. doi: 10.1093/infdis/171.6.1646.
Between February 1992 and February 1993, 12 patients were seen who were infected or colonized with methicillin-resistant strains of Staphylococcus aureus. The strains had decreased susceptibility to teicoplanin (MICs, 8-16 micrograms/mL). Field inversion gel electrophoresis showed the strains belonged to three related clones (A1, A2, and A3). The patients were though to have acquired the strains nosocomially. Consistent with results of laboratory studies of teicoplanin-resistant S. aureus, all but 1 strain expressed a 35-kDa membrane protein, and 9 strains expressed increased levels of penicillin-binding protein 2 complex. Six strains were isolated from patients treated with glycopeptides. These data suggest that nosocomial transmission of S. aureus with decreased teicoplanin susceptibility may occur during glycopeptide use and that such strains develop resistance by a mechanism associated with the appearance of a 35-kDa membrane protein. Surveillance is necessary to monitor for the potential selection of resistant clones that may be capable of dissemination.
在1992年2月至1993年2月期间,共诊治了12例感染或定植有耐甲氧西林金黄色葡萄球菌的患者。这些菌株对替考拉宁的敏感性降低(最低抑菌浓度为8 - 16微克/毫升)。脉冲场凝胶电泳显示这些菌株属于三个相关克隆(A1、A2和A3)。据认为这些患者是在医院获得的这些菌株。与耐替考拉宁金黄色葡萄球菌的实验室研究结果一致,除1株外,所有菌株均表达一种35 kDa的膜蛋白,9株表达的青霉素结合蛋白2复合物水平升高。6株菌株是从接受糖肽类药物治疗的患者中分离出来的。这些数据表明,在使用糖肽类药物期间可能会发生对替考拉宁敏感性降低的金黄色葡萄球菌的医院内传播,并且此类菌株通过与一种35 kDa膜蛋白出现相关的机制产生耐药性。有必要进行监测,以监控可能具有传播能力的耐药克隆的潜在选择情况。